Cong Wu1, Qian Xu1, Xinyue Chen1, Jiagang Liu1. 1. Department of Neurosurgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, People's Republic of China.
Abstract
BACKGROUND: Glioblastoma mutliforme is the most common and has the poorest prognosis of any malignant tumor of the central nervous system. Luteolin, the most abundant xanthone extracted from vegetables and medicinal plants, has been shown to have treatment effects in various cancer cell types. Luteolin is however, hydrophobic and has poor biocompatibility, which leads to low bioavailability. PATIENTS AND METHODS: In this study, folic acid modifiedpoly(ethylene glycol)-poly(e-caprolactone) (Fa-PEG-PCL) nano-micelles was used to encapsulate the luteolin, creating luteolin loaded PEG-PCL (Lut/Fa-PEG-PCL) micelles to treat glioma both in vitro and in vivo. RESULTS: When compared with the free luteolin and Lut/MPEG-PCL, Lut/Fa-PEG-PCL induced a significant cell growth inhibition and more apoptosis of GL261 cells both in vitro and in vivo. The safety assessment also showed no obvious side effects were observed in mice which were administrated with free luteolin or Lut/MPEG-PCL and Lut/Fa-PEG-PCL. CONCLUSION: These results suggested Lut/Fa-PEG-PCL may be used as an excellent intravenously injectable formulation for the treatment and chemoprevention.
BACKGROUND: Glioblastoma mutliforme is the most common and has the poorest prognosis of any malignant tumor of the central nervous system. Luteolin, the most abundant xanthone extracted from vegetables and medicinal plants, has been shown to have treatment effects in various cancer cell types. Luteolin is however, hydrophobic and has poor biocompatibility, which leads to low bioavailability. PATIENTS AND METHODS: In this study, folic acid modifiedpoly(ethylene glycol)-poly(e-caprolactone) (Fa-PEG-PCL) nano-micelles was used to encapsulate the luteolin, creating luteolin loaded PEG-PCL (Lut/Fa-PEG-PCL) micelles to treat glioma both in vitro and in vivo. RESULTS: When compared with the free luteolin and Lut/MPEG-PCL, Lut/Fa-PEG-PCL induced a significant cell growth inhibition and more apoptosis of GL261 cells both in vitro and in vivo. The safety assessment also showed no obvious side effects were observed in mice which were administrated with free luteolin or Lut/MPEG-PCL and Lut/Fa-PEG-PCL. CONCLUSION: These results suggested Lut/Fa-PEG-PCL may be used as an excellent intravenously injectable formulation for the treatment and chemoprevention.
Authors: Mahmoud A Al-Qudah; Noor K Otoom; Hala I Al-Jaber; Ayman M Saleh; Musa H Abu Zarga; Fatma U Afifi; Sultan T Abu Orabi Journal: Nat Prod Res Date: 2017-03-24 Impact factor: 2.861
Authors: Haidy Abbas; Nesrine S El Sayed; Nancy Abdel Hamid Abou Youssef; Passent M E Gaafar; Mohamed R Mousa; Ahmed M Fayez; Manal A Elsheikh Journal: Pharmaceutics Date: 2022-05-06 Impact factor: 6.525
Authors: Gabriel Nery de Albuquerque Rego; Arielly da Hora Alves; Mariana Penteado Nucci; Javier Bustamante Mamani; Fernando Anselmo de Oliveira; Lionel Fernel Gamarra Journal: Int J Mol Sci Date: 2020-06-24 Impact factor: 5.923
Authors: Manal A Elsheikh; Yasmin A El-Feky; Majid Mohammad Al-Sawahli; Merhan E Ali; Ahmed M Fayez; Haidy Abbas Journal: Pharmaceutics Date: 2022-03-05 Impact factor: 6.321